Phase 2
Completed N=53
Comparison of PET/CT vs. PET/MRI Using 2 Radiopharmaceuticals
Cancer Diagnosis · Diagnostic Techniques and Procedures · Diagnostic Imaging
Source: ClinicalTrials.gov NCT03125629 ↗
Enrolled (actual)
53
Serious AEs
0.0%
Results posted
Apr 2021
Primary outcomePrimary: Absolute Accuracy of SUV Max of PET/CT vs PET/MRI — 1.78; 1.08; 0.54; 0.51 ratio
Summary
This clinical trial studies how well positron emission tomography (PET)/computed tomography (CT) works compared to PET/magnetic resonance imaging (MRI) in evaluating patients with cancer. PET/CT and PET/MRI may determine which scanner is best for the patient's type of cancer and other types of cancers.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Absolute Accuracy of SUV Max of PET/CT vs PET/MRI |
1.78; 1.08; 0.54; 0.51; 0.79; 0.94 | — |
| SECONDARY PET/CT vs PET/MRI Difference in Standardized Uptake Value Max (SUVmax), by Radiotracer |
48.95; 5.71; 17.34; 11.24; 3.77; 52.63 | — |
Eligibility Criteria
INCLUSION CRITERIA
- Cancer diagnosis
- Capable of complying with study procedures
- Able to remain still for duration of imaging procedure (approximately 90 minutes total)
- Written informed consent
EXCLUSION CRITERIA
- Pregnant or nursing
- Metallic implants
- Impaired renal function
Data sourced from ClinicalTrials.gov (NCT03125629). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.